publication venue for
- VV116 as a potential treatment for COVID-19.. 24. 2023
- Ensitrelvir as a potential treatment for COVID-19.. 23. 2022
- Treatment of severe COVID-19: an evolving paradigm.. 23. 2022
- Current and emerging immunomodulators for treatment of SARS-CoV2 infection (COVID-19).. 23. 2022
- An update on naltrexone/bupropion extended-release in the treatment of obesity.. 17. 2016
- The therapeutic potential of vasopressin in cardiopulmonary resuscitation.. 6. 2005
- Letter to editor - a response to: 'efficacy and safety of triple combination therapy for treating chronic obstructive pulmonary disease: an expert review'. 2021
- Selected highlights from the 54th annual scientific session of the American College of Cardiology, Orlando, USA, 6-9 March 2005. 2005
- Will tyrosine kinase inhibitors be part of the treatment armamentarium for CML in the future?. 19. 2018
- Identifying the challenges of biomarkers that predict response to HER2-directed therapies.. 14. 2013
- Metformin as a potential treatment for COVID-19. 2023
- Montelukast as a potential treatment for COVID-19. 2023
- The pharmacotherapeutic management of nail unit and acral melanomas. 2022
- Combined medical strategies for the management of type 2 diabetes mellitus and obesity in adults. 2021
- An update on pharmacotherapeutic strategies for obesity. 2021
- State-of-the-art pharmacotherapy for diabetic neuropathy. 2020
- An evaluation of the efficacy and safety of erdafitinib for the treatment of bladder cancer. 2020
- An up-to-date evaluation of lorcaserin hydrochloride for the treatment of obesity. 2019
- Pharmacotherapy for onychomycosis: new and emerging treatments. 2019
- Treating obesity in patients with cardiovascular disease: the pharmacotherapeutic options. 2019
- Pharmacotherapy for obesity in individuals with type 2 diabetes. 2018
- A pangenotypic, single tablet regimen of sofosbuvir/velpatasvir for the treatment of chronic hepatitis C infection. 2017
- Advancing treatment options for chronic idiopathic constipation. 2015
- Lorcaserin Hcl for the treatment of obesity. 2015
- Advances in pharmacotherapy for allergic conjunctivitis. 2015
- Therapies for triple negative breast cancer. 2015
- Tolterodine for the treatment of urge urinary incontinence. 2013
- Delayed-release prednisone - a new approach to an old therapy. 2013
- Sunitinib malate for the treatment of pancreas malignancies--where does it fit? 2013
- Dacomitinib, a new therapy for the treatment of non-small cell lung cancer. 2013
- Eribulin mesylate for the treatment of breast cancer. 2010
- Tolterodine extended-release for overactive bladder. 2009
- Treatment of acute bacterial exacerbations of chronic bronchitis. 2009
- Pathophysiologic basis for the medical management of portal hypertension. 2009
- Treatment of patients with colorectal cancer: emphasis on liver metastases. 2009
- Management of painful diabetic neuropathy. 2008
- Azacitidine and the beginnings of therapeutic epigenetic modulation. 2008
- Current breast cancer risks of hormone replacement therapy in postmenopausal women. 2006
- Biliary tract cancers: current concepts and controversies. 2005
- Losartan for the treatment of hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study. 2004
- Idiopathic pulmonary fibrosis: emerging concepts on pharmacotherapy. 2004
- The therapeutic potential of ximelagatran to become the anticoagulant of choice in medicine: a review of recently completed clinical trials. 2004
- Donepezil: a clinical review of current and emerging indications. 2004
- Entacapone in the management of Parkinson's disease. 2002
- Botulinum toxin for the treatment of cervical dystonia. 2001
- Low molecular weight heparins. 2000
- Pharmacotherapy of gastroparesis. 2000